Condition
Causalgia
Total Trials
7
Recruiting
0
Active
0
Completed
2
Success Rate
50.0%-37% vs avg
Key Insights
Highlights
Success Rate
50% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 90/100
Termination Rate
28.6%
2 terminated out of 7 trials
Success Rate
50.0%
-36.5% vs benchmark
Late-Stage Pipeline
14%
1 trials in Phase 3/4
Results Transparency
0%
0 of 2 completed with results
Key Signals
50% success
Data Visualizations
Phase Distribution
5Total
Not Applicable (3)
P 2 (1)
P 4 (1)
Trial Status
Completed2
Terminated2
Enrolling By Invitation1
Unknown1
Not Yet Recruiting1
Trial Success Rate
50.0%
Benchmark: 86.5%
Based on 2 completed trials
Clinical Trials (7)
Showing 7 of 7 trials
NCT06306157Phase 4Enrolling By Invitation
Low Dose Naltrexone Therapy for Complex Regional Pain Syndrome
NCT07639060Not Yet Recruiting
Prospective Case Series Evaluating 6-Month and 12-Month Outcomes After Cryoneurolysis for Chronic Pain
NCT07170722Not ApplicableCompleted
Sub-threshold DRG Stimulation vs Sham in Established Responders
NCT03954080Not ApplicableCompleted
Trialing of ISS in Patients With CRPS
NCT02667717Not ApplicableTerminated
Efficacy and Safety of a Learning Program of Self- Rehabilitation Exercises by Mirror Therapy
NCT01088256Phase 2TerminatedPrimary
Efficacy of Etoricoxib on Peripheral Hyperalgesia
NCT01523379UnknownPrimary
Efficacy of Parecoxib on Patients With CRPS
Showing all 7 trials